COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?

Autor: Thangaraju P; Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., Gurunthalingam MP; Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., Varthya S; Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India., Venkatesan S; Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., Thangaraju E; Associate Professor, Department of EEE, AKT Memeorial College of Engineering and Technology, Kallakurichi, Tamil Nadu, India.
Jazyk: angličtina
Zdroj: Journal of family medicine and primary care [J Family Med Prim Care] 2020 May 31; Vol. 9 (5), pp. 2172-2175. Date of Electronic Publication: 2020 May 31 (Print Publication: 2020).
DOI: 10.4103/jfmpc.jfmpc_422_20
Abstrakt: Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some emergency measure by pharmacological intervention till a newer drug available in the market.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2020 Journal of Family Medicine and Primary Care.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje